Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 11017 - 11024 of 12008 results
Court Rejects Urologists’ Appeal to Overturn Regulatory Changes to Stark Law
June 20, 2013| Blog| Viewpoint
Federal District Court Upholds Stark Regulation Ban on Physician-Owned Under Arrangement Service Providers
June 19, 2013| Advisory| Viewpoint
Texas Makes Changes to Medicaid Laws and Programs
June 19, 2013| Blog| Viewpoint
Equal Pay Act: Male employee's strong negotiating skills not a "factor other than sex" to justify pay differential
June 18, 2013| Blog| Viewpoint
Counterfeits, Trademark Infringement, and Contributory Liability: Your Vendors are Your Problem
June 18, 2013| Blog| Viewpoint
More About Trademark Surnames: The Borghese Dispute
June 17, 2013| Blog| Viewpoint
DOE Releases New Protocols to Determine Energy Efficiency Savings
June 17, 2013| Article| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update on June 17, 2013
June 17, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|